InvestorsHub Logo
icon url

zigfraud

04/20/06 9:50 AM

#2114 RE: hopingforagain #2112

DD is fun...recycling BS

Zig, I don't think this qualifies for you winning a medal for a "Save the Earth by Recycling" campaign...I mean, can you be credited for recycling your own BS?

Check these old gems out...Sound familiar? Rob Tillman - Where have we seen that name before? Oh, that's right - an ADVISOR! Meetings with Nike in story #2? I knew that we'd seen this same crap before?

NEWBIES - BEWARE OF THIS GUY AND HIS BS MACHINE!

Story #1

SCOTTSDALE, Ariz., Jun 22, 2004 (BUSINESS WIRE) -- Motion DNA (OTC:MOTD) President Zig Ziegler and Vice President of Technology Jason Bodine spent the weekend in a closed-door meeting with Ola Grimsby, chairman of the board of the Ola Grimsby Institute (OGI) and Rob Tillman, a chief instructor of OGI and a former vice president of HealthSouth Corp. Grimsby and Tillman, currently serving as members of the Motion DNA advisory board, requested the meeting weeks ago during a telephone conference. The meeting topics focused on a potential strategic partnership between Motion DNA and the Ola Grimsby Institute.
In an effort to speed up the completion of phase three of the BioTrainer, Motion DNA is interested in reaching an agreement with the OGI. The deal could help Motion DNA save an estimated 18 months of research and development. Under a proposed agreement, the OGI would become the educational arm of Motion DNA, conducting classes and seminars on the use of Motion DNA's analysis in measuring the actual functional range of motion of injured and healthy patients.

"This would provide the physical therapy market with much-needed support information to assist with reimbursement from insurance companies and the validation of the need for surgical and clinical procedures," said Ziegler. "OGI instructors would receive training and use of Motion DNA products as part of its training program for physical therapists." Officials at Motion DNA believe this move will help the company fight its biggest battle, "education on the existence and use of motion analysis as an accepted, non-threatening procedure."

Currently the OGI has educated thousands of physical therapists around the globe. Over 36,000 physical therapists have attended OGI programs, which include the OGI's world renowned doctorate programs for physical and manual therapy. OGI graduates currently are leaders in some of the world's top physical therapy offices, including HealthSouth, Physiotherapy Associates and NovaCare.

An agreement would also give Motion DNA's development team access to the OGI's research on therapeutic procedures, multiple and single joint range of motion evaluations, and the extensive database of physical therapists around the world. Students enrolled in the OGI's continuing education programs will be eligible to obtain grants to fund the use of Motion DNA services to conduct much-needed continued research in physical medicine.

For more information about Motion DNA Corp., visit www.motiondnacorp.com. Visit the Ola Grimsby Institute at www.olagrimsby.com.

All press releases may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products, which we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.

Story #2

SCOTTSDALE, Ariz., Jun 21, 2004 (BUSINESS WIRE) -- Over 10,000 athletic trainers from collegiate and professional athletic programs were introduced to the power of Motion DNA Corporation (OTC:MOTD) and its analysis programs at the annual National Athletic Trainer's Association (NATA) Convention in Baltimore last week. According to company representatives in attendance, the NATA convention which included over 500 exhibitors, Motion DNA's booth was the most advanced technology available for participants.
"Motion DNA gave today's athletic trainers a glimpse at what sports medicine is expected to look like in the future," said Bobby Thompson, member of Motion DNA's Board of Advisors. Thompson, a former NFL player, was forced to end his career after injuries limited his playing days with the Oakland Raiders. "I joined the Motion DNA team because trainers could have used Motion DNA to help extend my playing career," said Thompson. "My injuries could have been prevented, had they been able to identify what repetitive motion was contributing to them."

Athletic trainers visiting the Motion DNA booth appeared amazed at the accuracy of the technology, viewing and receiving simple analyses being conducted on the spot. Demonstrating the power of its technology, Motion DNA identified the existence of and reasons for physical limitations in the participants. Motion DNA technicians spent their days analyzing posture during individual golf swings; measuring step and posture during walking and running; and identifying potential injuries during strength training exercises and daily activities. Motion DNA technicians also provided examples analyses of individual joint coordination and range of motion testing.

"Motion DNA quickly identified traits in my running that contribute to some pain I have been feeling in my hip," said Terri Hudson of the National Center for Sports Safety. Hudson received an analysis of two, 20 second runs on a treadmill.

"In our opinions, Motion DNA would have to be considered one of the highlights of the convention," said Motion DNA Motion DNA President, Zig Ziegler. "Every athletic trainer we spoke to at the convention agreed that 'they need access to Motion DNA's technology to improve the potential for complete return from injuries' for their athletes."

The convention, as expected allowed Motion DNA to demonstrate its analysis to the programs atop its list of potential customers. Receiving demonstrations of the power and requesting proposals included decision makers from the universities of Connecticut, Alabama, Miami, Mississippi, Arkansas, BYU, Notre Dame, Oklahoma, Texas, and Auburn, to name a few. Representatives from professional teams in football, basketball, and baseball also expressed interest in the Motion DNA products and services.

"Our goal was to leave the convention closer to our goal of 10 collegiate programs a utilizing our motion analysis services and 100 programs interested in acquiring our BioTrainer for day to day use," said Ziegler. "We surpassed those goals and received some unexpected interest from other companies in the industries."

Motion DNA expects to make several announcements over the next 30 days regarding strategic alliances and new customers as a result of this convention. "We were approached by several major suppliers of athletic training and medical device companies interested in adding our technology as a compliment to their products," said Ziegler. "We are currently exchanging the proper legal documents, to keep protect the interests of the parties involved. Once that is complete, we expect to identify those potential relationships."

This week, Ziegler and his team of developers return to work on the company's flagship product, the BioTrainer. Ziegler will make trips to Portland and Eugene, Oregon and Seattle, Washington for presentation with professional and collegiate programs in those cities. While in the area, Ziegler has meetings scheduled with the Seattle Seahawks, University of Washington, University of Oregon, and Portland Trailblazers. Ziegler also expects a brief meeting to introduce the technology to officials from Nike and Adidas corporations. The company believes the major shoe and apparel manufacturers would be ideal strategic partners at this time for the company.


icon url

wettstain

04/20/06 12:19 PM

#2116 RE: hopingforagain #2112

as much as i had hoped zig would make good on at least one or two of his pr's over the past months,,,,, i do not believe anything about nike,, that is why MENTIONED,, not a fact, his patent,, he had 2 buyout offers from millar, and he could still been salesman for mtdx, but they were turned down, and no one else will offer tht. wish and hope i am wrong, but in dec he was filing a patent for formula 21, no news of that anymore,,,,,, even the latest of the new managment and zig stepping down and be completed as early as next week,,,, that was 3 weeks ago,,, everything, and not one of them has he followed thru on,,,,,,